Design Pharmaceuticals, Inc. — Form D
Design Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-02. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-02
- Form: D
- Accession: 0001908215-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 1
- Date of first sale: 2022-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431865
Issuer
- Name: Design Pharmaceuticals, Inc.
- CIK: 0001908215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 237 PUTNAM AVENUE, CAMBRIDGE, MA, 02139
- Phone: 617-553-1402
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Olivier Clyti | Director | Cambridge, MA |
| Fred Dom | Director | Cambridge, MA |
| John Hastewell | Director | Cambridge, MA |
| Dirk Loeffert | Director | Cambridge, MA |
| Rob Nicol | Director | Cambridge, MA |
| Dirk Loeffert | Executive Officer | Cambridge, MA |
| Rob Nicol | Executive Officer | Cambridge, MA |
More